Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...Soriot is already among the highest-paid bosses in the FTSE with a £16.9mn deal in 2023 and takes home more than the chiefs of European pharmaceutical rivals....
...Western pharmaceutical companies are in talks with alternative suppliers in response to draft US legislation seeking to restrict an important Chinese drug developer and manufacturer over national security...
...Still, Delaware, Inc is going to have to decide whether its brand should be based on being an even-handed, dispassionate system or something more corporate-friendly, designed to keep up in a regulatory race...
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...Ireland’s economy has officially entered recession after contracting by 1.9 per cent in the third quarter, pushed lower by a drop in pharmaceutical exports....
...Pharmaceutical companies also have a key role to play in providing affordable access to these essential products. The global industry’s response to date has been inadequate and fragmented....
...Two Humira biosimilars — from Organon in collaboration with Samsung Bioepis and Teva Pharmaceuticals working with Alvotech — earlier this year became the first to be granted interchangeable status by the...
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...This is an audio transcript of the Behind the Money podcast episode: ‘Ozempic’s unconventional origins’ Michela Tindera It’s November, and the FT’s global pharmaceutical editor Hannah Kuchler is in Copenhagen...
...GLP-1s now underpin a weight loss drug, Wegovy, developed by pharmaceutical group Novo Nordisk....
...This has led to western pharmaceutical regulators struggling to enforce oversight of Chinese manufacturers....
...communique issued on Wednesday, the party’s deeply feared internal watchdog, the Central Commission for Discipline Inspection, said it would prioritise investigation into the finance, agricultural and pharmaceutical...
...Emblaveo, marketed in Europe by US pharmaceutical company Pfizer, combines two existing medicines to tackle so-called Gram-negative bacteria that are among the leading drug-resistance threats....
...It is a similar milestone-based structure to many partnerships in the pharmaceutical industry....
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...Over the decades, studies have repeatedly shown these gender disparities persisting: men are more likely to be prescribed painkillers while women have to make do with psycho-pharmaceutical interventions....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...Cheaper valuations have finally drawn cash-rich pharmaceutical makers back to biotechs. Their aim, as always, is to replenish their drug pipelines affordably. Relief is sorely needed....
...It needs further deals to replenish its pharmaceuticals pipeline....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
...Neither McNeil nor Carson could put a figure on the number of ETFs that might have bypassed UK, depriving the London stock exchange of their listing and UK investors of the opportunity to access them....
International Edition